Medicinal composition for treating child asthmatic suffocating pneumonia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and pneumonia technology, applied in the field of medicine, can solve problems such as small side effects, decreased drug sensitivity, negative protein balance, etc.
Active Publication Date: 2012-08-01
JIANGSU SUZHONG PHARM GRP CO LTD
View PDF2 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there are actually the following problems: ① Insufficient treatment, because the basic pathogen of airway inflammation is syncytial virus, and there is no specific drug for this virus in Western medicine at present; ② Regarding the use of hormones, in infants and young children In addition to the common side effects of hormones, children who use hormones repeatedly for a long time, bec
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0019] Example 1, raw material drug weight ratio: 3 parts of saponins, 9 parts of loquat leaves, 15 parts of hops, 15 parts of winter melon seeds, 9 parts of orchid vanilla, 9 parts of bellflower, 10 parts of red clover, 6 parts of peucedanum, 1 part of borneol share.
Embodiment 2
[0020] Example 2, raw material drug weight ratio: 1 part of saponins, 6 parts of loquat leaves, 10 parts of hops, 10 parts of wax gourd seeds, 6 parts of blue vanilla, 6 parts of bellflower, 15 parts of red clover, 9 parts of peucedanum, 3 parts of borneol share.
Embodiment 3
[0021] Example 3, raw material drug weight ratio: 2 parts of saponins, 8 parts of loquat leaves, 12 parts of hops, 12 parts of wax gourd seeds, 8 parts of blue vanilla, 8 parts of bellflower, 12 parts of red clover, 8 parts of peucedanum, 2 parts of borneol share.
[0022] The preparation steps of Examples 1 to 3 are as follows: take loquat leaves, hops, wax gourd seeds, platycodon grandiflorum, red clover, and Radix Peucedanum, add water and decoct for 20 minutes, then add orchid vanilla and decoct for 10 minutes, filter, extract the filtrate, add to the medicinal residues Continue decocting with the same amount of water as the filtrate for 20 minutes, filter, extract the filtrate, combine the filtrates, cool down to 30°C, add acacia powder and borneol, stir well, and filter to obtain the medicinal solution.
[0023] Daily dose setting: when the child’s weight is less than 10kg, 1 part of the weight ratio of raw materials is 0.2g; when the weight of the child is 10-30kg, 1 pa...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicinal composition for treating child asthmatic suffocating pneumonia. The medicinal composition is characterized by being processed from multiple Chinese medicines in parts by weight: 1-3 parts of Chinese honey locust, 6-9 parts of loguat leaf, 10-15 parts of european hop flower, 10-15 parts of waxgourd seed, 6-9 parts of common bluebeard herb, 6-9 parts of platycodon root, 10-15 parts of red clover flower and inflorescence, 6-9 parts of whiteflower hogfennel root and 1-3 parts of borneol. As proved by clinical experiments, the medicinal composition for treating child asthmatic suffocating pneumonia has the characteristics of good curative effect and high safety, and is worthy of clinical application and popularization.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating children with asthmatic pneumonia. Background technique [0002] Asthmatic pneumonia, also known as bronchiolitis, is more common in children under 2 years old, and occurs frequently in winter and spring. It is a common lower respiratory tract infectious disease in infants and young children. The main pathogens of asthmatic pneumonia are viruses, the most common being respiratory syncytial virus RSV. After the onset, it manifests as cough, wheezing, dyspnea, and extensive wheezing in the lungs. In severe cases, cardiac insufficiency and respiratory failure occur. The basis and pathological features of its asthma attack are airway inflammation and hyperresponsiveness, mainly manifested by inflammatory cell infiltration and epithelial cell damage mainly composed of eosinophils. Eosinophils are powerful pro-inflammatory cells. Activating T lymphocy...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more